SABCS2010 - Live - Cure magzine
San Antonio Breast Cancer Symposium - 2010 daily report by Cure magazine:
http://media.curetoday.com/sabcs2010/ |
Re: SABCS2010 - Live - Cure magzine
|
Re: SABCS2010 - Live - Cure magzine
Thanks. There looks like alot of good links to information about her2.
|
Re: SABCS2010 - Live - Cure magzine
Here's another one of her interviews (in October) with another physician on the subject - transcript included:
http://www.medscape.com/viewarticle/730703 |
Re: SABCS2010 - Live - Cure magzine
http://curetoday.com/index.cfm/fusea...rticle_id/1600
Drug Combo Tames HER2-Positive Breast Cancer BY MELISSA WEBER http://her2support.org/index.cfm/fus...rticle_id/1600 Treatment for HER2-positive breast cancer turned a corner more than a decade ago with the approval of Herceptin (trastuzumab). More recently, another successful drug called Tykerb (lapatinib) hit the market. The question then became whether Herceptin, Tykerb or a combination of the two would be most effective in stifling the aggressive disease. Two studies presented at the San Antonio Breast Cancer Symposium offer some clues. http://media.curetoday.com/sabcs2010/ ** Don't forget to sign up at the Breastcancer.org site (Elaine's post on the Breast Cancer Meeting Highlights Forum below this one) to get the complete transcript of SABCS. |
Re: SABCS2010 - Live - Cure magzine
Don't forget to sign up at the Breastcancer.org site (Elaine's post on the Breast Cancer Meeting Highlights Forum below this one) to receive the e-mail alert when the complete transcript of SABCS is available (Dec 22).
|
All times are GMT -7. The time now is 10:34 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021